COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding

Lydia L Shook1,2, Parisa N Fallah1, Jason N Silberman1

  • 1Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Insights

The COVID-19 pandemic highlighted the need for optimized vaccines for pregnant individuals and newborns. This review summarizes current research on COVID-19 vaccination in pregnancy and lactation, guiding future maternal vaccine strategies.

Area of Science:

  • Immunology
  • Maternal Health
  • Vaccinology

Background:

  • Pregnant individuals and newborns face increased risks from COVID-19.
  • COVID-19 vaccines were rapidly developed and distributed, including for pregnant and lactating populations.
  • Pregnant individuals were not initially included in COVID-19 vaccine trials.

Purpose of the Study:

  • To review existing literature on COVID-19 vaccination during pregnancy and lactation.
  • To identify knowledge gaps and future research opportunities.
  • To inform the development and implementation of maternal vaccination strategies.

Main Methods:

  • Literature review of studies on COVID-19 vaccines in pregnant and lactating individuals.
  • Synthesis of data on vaccine safety and immunogenicity.
  • Identification of research priorities.

Main Results:

  • Data on COVID-19 vaccine safety and immunogenicity in pregnant and lactating populations are accumulating.
  • Evidence suggests COVID-19 vaccines are generally safe and effective in these groups.
  • Further research is needed to fully understand long-term effects and optimal strategies.

Conclusions:

  • COVID-19 vaccination during pregnancy and lactation is crucial for protecting maternal and infant health.
  • Continued research is essential for refining maternal vaccine recommendations.
  • This review provides a foundation for future maternal immunization initiatives.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
46.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.1K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
511
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
516
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
201